James N. Arnold
London, ENG SE11UL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer.
Journal: Science translational medicine
Published: August 06, 2025
Current strategies for armoring chimeric antigen receptor T-cells to overcome barriers of the solid tumor microenvironment.
Journal: Frontiers in immunology
Published: June 09, 2025
CD47 Knock-Out Using CRISPR-Cas9 RNA Lipid Nanocarriers Results in Reduced Mesenchymal Glioblastoma Growth In Vivo.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 28, 2024
PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.
Journal: Cancer research
Published: December 08, 2023
Perivascular tumor-associated macrophages and their role in cancer progression.
Journal: Essays in biochemistry
Published: January 27, 2023
The effects of radiation therapy on the macrophage response in cancer.
Journal: Frontiers in oncology
Published: August 16, 2022
LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer.
Journal: Developmental cell
Published: June 23, 2022
Immune cell-antibody interactions in health and disease.
Journal: Clinical and experimental immunology
Published: June 20, 2022
Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue.
Journal: PloS one
Published: May 24, 2022
Tinker, tailor, soldier, cell: the role of C-type lectins in the defense and promotion of disease.
Journal: Protein & cell
Published: January 24, 2022
Last Updated: 09/26/2026